DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR ACETIC ACID

« Back to Dashboard

Clinical Trials for Acetic Acid

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00003697	Dimethylxanthenone Acetic Acid in Treating Patients With Solid Tumors	Completed	University of Glasgow	Phase 1	1995-10-01	RATIONALE: Dimethylxanthenone acetic acid may stop the growth of cancer cells by stopping blood flow to the tumor. PURPOSE: Phase I trial to study the effectiveness of dimethylxanthenone acetic acid in treating patients with solid tumors that have not responded to previous therapy.
NCT00044213	Trial to Assess Chelation Therapy (TACT)	Completed	National Center for Complementary and Integrative Health (NCCIH)	Phase 3	2003-09-01	The purpose of this study is to determine the safety and effectiveness of ethylene diamine tetra-acetic (EDTA) chelation therapy in individuals with coronary artery disease.
NCT00044213	Trial to Assess Chelation Therapy (TACT)	Completed	National Heart, Lung, and Blood Institute (NHLBI)	Phase 3	2003-09-01	The purpose of this study is to determine the safety and effectiveness of ethylene diamine tetra-acetic (EDTA) chelation therapy in individuals with coronary artery disease.
NCT00044213	Trial to Assess Chelation Therapy (TACT)	Completed	Mt. Sinai Medical Center, Miami	Phase 3	2003-09-01	The purpose of this study is to determine the safety and effectiveness of ethylene diamine tetra-acetic (EDTA) chelation therapy in individuals with coronary artery disease.
NCT00051545	Seocalcitol Versus Placebo in the Adjuvant Treatment of Hepatocellular Carcinoma	Terminated	LEO Pharma	Phase 3	1999-11-01	To evaluate the efficacy of Seocalcitol in prolonging time to relapse following intended curative resection or percutaneous ablative treatment, i.e. percutaneous ethanol injection(s), percutaneous acetic acid injection(s), percutaneous microwave coagulation therapy, or percutaneous radiofrequency ablation for hepatocellular carcinoma (HCC).

Clinical Trial Conditions for Acetic Acid

Condition Name

Condition Name for Acetic Acid
Intervention	Trials
Cervical Cancer	3
Unspecified Adult Solid Tumor, Protocol Specific	3
Extensive Stage Small Cell Lung Cancer	2
Type 2 Diabetes Mellitus	2

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Acetic Acid
Intervention	Trials
Uterine Cervical Neoplasms	4
Diabetes Mellitus	4
Diabetes Mellitus, Type 2	3
Fibrosis	3

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Acetic Acid

Trials by Country

Trials by Country for Acetic Acid
Location	Trials
United States	47
Canada	7
Egypt	6
Italy	6
United Kingdom	5

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Acetic Acid
Location	Trials
California	6
New York	4
Texas	4
Florida	3
Minnesota	3

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Acetic Acid

Clinical Trial Phase

Clinical Trial Phase for Acetic Acid
Clinical Trial Phase	Trials
Phase 4	10
Phase 3	6
Phase 2/Phase 3	3

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Acetic Acid
Clinical Trial Phase	Trials
Completed	24
Recruiting	16
Not yet recruiting	5

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Acetic Acid

Sponsor Name

Sponsor Name for Acetic Acid
Sponsor	Trials
National Cancer Institute (NCI)	7
ISDIN	3
M.D. Anderson Cancer Center	3

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Acetic Acid
Sponsor	Trials
Other	70
Industry	13
NIH	10

Export unavailable in trial.
Subscribe for complete access.